# Phase 427: Tier 1+ #6 Aging 深掘り — K_aging framework

## Pass-1 #6 (Aging, DOI 20151623) を引き継ぐ

Pass-1 #6 では:
- Hayflick limit (1961)
- Hallmarks of Aging (López-Otín 2013, 2023)
- Telomere biology (Blackburn-Greider-Szostak Nobel 2009)
- Yamanaka factors OSKM (2006/2007 Nobel 2012)
- Senolytics, mTOR/rapamycin
- 言及範囲

を扱ったが、**K_aging operator-algebraic 定義**、**Biological Age Modular Hamiltonian**、**Epigenetic clock (Horvath 2013) との接続** は未踏。

## Tier 1+ #6 の中心仮説

```
K_aging = -log ρ_organism
  where ρ_organism is density operator over cellular/molecular state of organism

Biological age ⇔ ⟨K_aging⟩ growth over chronological time
```

## 全体構想 (Phase 427-442, 16 phases)

```
Phase 427: 開幕 + K_aging framework ← 本ノート
Phase 428: Hallmarks of Aging (López-Otín 2013/2023 12 hallmarks)
Phase 429: K_aging = -log ρ_organism 厳密定義
Phase 430: Epigenetic clocks (Horvath 2013, GrimAge, PhenoAge, DunedinPACE)
Phase 431: Yamanaka factors (OSKM, partial reprogramming Ocampo 2016)
Phase 432: Cellular senescence (Hayflick 1961, senolytics)
Phase 433: Telomere biology (Blackburn-Greider-Szostak Nobel 2009)
Phase 434: Mitochondrial aging (Harman 1956, mtUPR)
Phase 435: Caloric restriction + mTOR + rapamycin + metformin
Phase 436: Longevity biotech (Altos Labs $3B 2022, Calico, Retro Biosciences)
Phase 437: Centenarians + Blue Zones (Okinawa, Sardinia)
Phase 438: Reprogramming therapy (Sinclair NMN, Conboy parabiosis)
Phase 439: AI-aging (Insilico Medicine, Gorbunova lab)
Phase 440: Pass-2 ロードマップ + budget
Phase 441: 10 predictions + polytope + 数値検証 (toy aging trajectory)
Phase 442: まとめ + Tier 1+ #7 Psychiatry への接続
```

## Tier 1+ #6 の 4 つの中心仮説 (H_A1-H_A4)

### H_A1: Organism is operator-algebraic state

```
Organism O は density operator ρ_organism で記述:
  ρ_organism = density over cellular states + epigenetic state + metabolites
  H_organism = L²(Cells × Epigenetic_marks × Metabolome × Proteome)
```

### H_A2: ⟨K_aging⟩ measures biological age

```
⟨K_aging⟩(t) = -Tr[ρ_organism(t) log ρ_organism(t)]

Hypothesis:
  ⟨K_aging⟩(t) ≈ a · t + b · (variance/disorder of cellular states)
  Healthy aging: linear growth
  Accelerated aging: super-linear
  Reprogramming: ⟨K_aging⟩ decreases (rejuvenation)
```

### H_A3: Epigenetic clocks measure K_aging projection

```
Horvath 2013 (Cell):
  353 CpG methylation sites
  Predicts chronological age within ±3 years
  
ITU view:
  Horvath clock = projection of ρ_epigenetic onto specific CpG basis
  ⟨K_aging⟩^{epigenetic projection} ≈ Horvath age

Subsequent clocks:
  GrimAge (Lu 2019 Aging) — mortality predictor
  PhenoAge (Levine 2018 Aging) — phenotype predictor
  DunedinPACE (Belsky 2022 eLife) — pace of aging
```

### H_A4: Reprogramming = K_aging modular flow reversal

```
Yamanaka OSKM 2006/2007 (Nobel 2012):
  Adult cell → iPSC via 4 transcription factors

Partial reprogramming (Ocampo et al. 2016 Cell):
  Cyclic OSKM expression rejuvenates without dedifferentiation
  Reverses Horvath clock in mice

ITU view: OSKM applies inverse modular flow on ρ_organism:
  σ_{-t}^{Yamanaka}(ρ_organism) → ρ_younger
  ⟨K_aging⟩ decreases
```

## 反証可能性

```
H_A1 反証: organism state が density operator で記述不可
H_A2 反証: ⟨K_aging⟩ と biological age 無相関
H_A3 反証: Horvath clock が K_aging projection と整合しない
H_A4 反証: Reprogramming で K_aging 減少しない

各々 epigenetic clock data (Horvath 公開 dataset) で test 可能。
```

## 2024 longevity industry landscape

```
Altos Labs (2022.1 launch, $3B funding):
  Hal Barron CEO, Yamanaka senior scientist
  Cellular rejuvenation programming
  No public products yet (2024)

Calico Labs (Google + AbbVie, 2013-):
  $1.5B+ invested
  Cynthia Kenyon (Daf-2 longevity)

Retro Biosciences (Sam Altman $180M 2022):
  10 yr longevity research

Insilico Medicine ($350M Series E 2024):
  AI drug discovery, aging hallmarks targeted

Loyal (FDA 2024.11 approved life extension drug for large dogs):
  First-ever FDA conditional approval for longevity

Rejuvenate Bio: gene therapy for aging dogs/humans

GLP-1 agonists (semaglutide, tirzepatide):
  Aging biomarker improvement noted (2024 studies)
```

---

#情報理論的統一理論 #ITU #Pass1.5 #Tier1plus #Aging #K_aging #Longevity #Phase427
